ARTICLE | Company News
Radius Health, Novartis deal
February 15, 2016 8:00 AM UTC
The companies partnered to evaluate Radius’ RAD1901 in combination with either Novartis’ ribociclib ( LEE011) or the pharma’s alpelisib ( BYL719) in studies to treat breast cancer. The partners will share expenses and jointly own data. ...